SLEEP Disorder in Patients with Multiple Sclerosis

Background: Multiple sclerosis (MS) is a neurological disease that usually presents in young adults, whose origin is unknown. It is the second leading cause of disability following car accidents. Usually people with MS do not complain of sleep disorders, only do so when they are asked. Sleep disorders in these patients are diagnosed below and can be up to three times more frequent than in the rest of the population. Some patients have more daytime sleepiness, increased sleep latency and nighttime awakenings. A therapeutic alternative for patients with MS and MS PP BR is the use of Rebif 44mcg Are refueled as one of the reactions of this the occurrence of insomnia medicine target

Objectives: Assess the condition of sleep in patients with multiple sclerosis (MS) treated with interferon beta 1 using scales and questionnaires.

Methods: We selected 88 patients with a diagnosis of multiple sclerosis which were applied to different scale and questionnaire are dream like sleep questionnaire, morningness and eveningness questionnaire, Epworth scale and insomnia medical instrument

Results: preliminary survey results reveal evaluated not significant sleep disorder in these patients.

Conclusions: Patients with multiple sclerosis outbreak under treatment with interferon beta remission 1a (Rebif 44mcg) have a range of morningness and eveningness intermediate to moderate morning. • Preliminary survey results reveal evaluated not significant sleep disorder in these patients.